UBS ASSET MANAGEMENT AMERICAS LLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 176 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$171,325,000
-33.6%
18,226
-45.9%
0.00%
Q2 2020$257,867,000
-1.2%
33,708
-20.2%
0.00%
Q1 2020$260,951,000
-50.3%
42,225
-2.1%
0.00%
Q4 2019$525,088,000
+10.7%
43,146
+5.1%
0.00%
Q3 2019$474,266,000
+76.0%
41,062
+52.2%
0.00%
Q2 2019$269,480,000
+72.9%
26,975
+123.0%
0.00%
Q1 2019$155,835,000
-15.2%
12,0990.0%0.00%
Q4 2018$183,784,000
-24.0%
12,0990.0%0.00%
Q3 2018$241,980,000
+2.6%
12,0990.0%0.00%
Q2 2018$235,931,000
-3.2%
12,0990.0%0.00%
Q1 2018$243,795,000
+85442.1%
12,099
+47.6%
0.00%
Q4 2016$285,000
-30.1%
8,199
-50.8%
0.00%
Q3 2016$408,000
+2.5%
16,6560.0%0.00%
Q2 2016$398,000
+26.3%
16,656
+23.8%
0.00%
Q1 2016$315,000
-26.7%
13,456
-5.6%
0.00%
Q4 2015$430,000
-24.0%
14,2560.0%0.00%
-100.0%
Q3 2015$566,000
-24.1%
14,256
+32.0%
0.00%0.0%
Q2 2015$746,000
+58.7%
10,799
+25.6%
0.00%
Q1 2015$470,000
+75.4%
8,599
+36.5%
0.00%
Q4 2014$268,000
+33.3%
6,2990.0%0.00%
Q3 2014$201,0006,2990.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,921,550$81,254,0004.00%
Palo Alto Investors LP 1,614,536$33,453,0002.49%
Ghost Tree Capital, LLC 100,000$2,072,0001.46%
March Altus Capital Management LP 146,418$3,034,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 296,458$6,143,0000.98%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,339$20,706,0000.83%
Visium Asset Management, LP 2,070,870$42,908,0000.67%
AlphaOne Investment Services, LLC 97,448$2,019,0000.54%
CONTINENTAL ADVISORS LLC 57,438$1,190,0000.28%
Tamarack Capital Management, LLC 64,080$1,222,0000.25%
View complete list of AMAG PHARMACEUTICALS INC shareholders